CervoMed is trading at $2.49, down 6.4% today, amid a lack of fresh company-specific news or filings to explain the downward move.
- The decline follows a sector-wide rebound in the previous session, suggesting a reversal of yesterday's gains.
- The move appears driven by general risk sentiment and inherent volatility in the small-cap biotech sector rather than any new fundamental developments.
- Broader market conditions remain mixed, providing little support for the stock during today's session.